Axcella Health  logo
Axcella Health AXLA

Quarterly report 2023-Q2
added 08-03-2023

report update icon

Axcella Health Total Current Liabilities 2011-2026 | AXLA

Annual Total Current Liabilities Axcella Health

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
14.1 M 10.2 M 7.78 M 8.36 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
14.1 M 7.78 M 10.1 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Aligos Therapeutics Aligos Therapeutics
ALGS
21.2 M $ 8.59 -1.49 % $ 84.9 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
11 M - -2.5 % $ 5.88 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
50.2 M $ 3.27 2.03 % $ 329 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
71.2 M - - $ 8.42 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
200 M - - $ 546 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
158 M $ 21.6 1.12 % $ 1.01 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
20.1 M - - $ 169 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
6.81 M - - $ 25.3 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
163 M $ 1.54 4.76 % $ 396 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.73 M $ 3.04 4.11 % $ 5 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
47.6 M $ 4.16 -0.72 % $ 445 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
130 M $ 25.23 4.6 % $ 3.21 B usaUSA
Chimerix Chimerix
CMRX
18.4 M - - $ 756 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
16.1 M - - $ 401 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
51 M $ 33.31 2.19 % $ 2.21 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
73.4 M $ 1.5 2.04 % $ 399 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Cidara Therapeutics Cidara Therapeutics
CDTX
49.6 M - - $ 1.41 B usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
4.1 M $ 2.59 3.19 % $ 1.15 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
81.1 M - - $ 1.2 B usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
12.4 M $ 4.55 7.12 % $ 306 B britainBritain